A detailed history of Traphagen Investment Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 10,483 shares of JNJ stock, worth $1.66 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
10,483
Previous 10,416 0.64%
Holding current value
$1.66 Million
Previous $1.52 Million 11.56%
% of portfolio
0.2%
Previous 0.19%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$145.48 - $167.38 $9,747 - $11,214
67 Added 0.64%
10,483 $1.7 Million
Q2 2024

Jul 23, 2024

BUY
$144.38 - $157.78 $35,806 - $39,129
248 Added 2.44%
10,416 $1.52 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $1.58 Million - $1.65 Million
10,168 New
10,168 $1.61 Billion
Q4 2023

Jun 17, 2024

BUY
$145.6 - $158.88 $6,843 - $7,467
47 Added 0.46%
10,215 $1.6 Billion
Q3 2023

Jun 17, 2024

BUY
$155.75 - $174.48 $84,416 - $94,568
542 Added 5.33%
10,710 $1.67 Billion
Q2 2023

Jun 17, 2024

SELL
$154.35 - $166.11 $33,648 - $36,211
-218 Reduced 2.14%
9,950 $1.65 Billion
Q1 2023

Jun 17, 2024

BUY
$151.05 - $180.26 $61,628 - $73,546
408 Added 5.0%
8,576 $1.33 Billion
Q4 2022

Jun 17, 2024

SELL
$160.2 - $179.79 $320,400 - $359,580
-2,000 Reduced 19.67%
8,168 $1.44 Billion
Q3 2022

Jun 17, 2024

SELL
$161.33 - $179.52 $20,811 - $23,158
-129 Reduced 1.57%
8,079 $1.32 Billion
Q2 2022

Jun 17, 2024

SELL
$168.19 - $186.01 $329,652 - $364,579
-1,960 Reduced 19.28%
8,208 $1.46 Billion
Q1 2022

Jun 17, 2024

SELL
$158.14 - $179.59 $82,549 - $93,745
-522 Reduced 6.28%
7,789 $1.38 Billion
Q4 2021

Jun 17, 2024

SELL
$155.93 - $173.01 $289,562 - $321,279
-1,857 Reduced 18.26%
8,311 $1.42 Billion
Q3 2021

Jun 17, 2024

BUY
$161.5 - $179.47 $34,561 - $38,406
214 Added 2.61%
8,398 $1.36 Billion
Q2 2021

Jun 17, 2024

SELL
$159.48 - $171.07 $83,886 - $89,982
-526 Reduced 6.04%
8,184 $1.35 Billion
Q1 2021

Jun 17, 2024

SELL
$153.07 - $170.48 $223,176 - $248,559
-1,458 Reduced 14.34%
8,710 $1.43 Billion
Q4 2020

Jun 17, 2024

SELL
$137.11 - $157.38 $5.64 Million - $6.48 Million
-41,147 Reduced 82.29%
8,853 $1.39 Billion
Q3 2020

Jun 17, 2024

BUY
$140.38 - $153.83 $5.96 Million - $6.54 Million
42,488 Added 565.6%
50,000 $12 Million
Q2 2020

Jun 17, 2024

SELL
$128.81 - $155.51 $342,119 - $413,034
-2,656 Reduced 26.12%
7,512 $1.06 Billion
Q1 2020

Jun 17, 2024

SELL
$111.14 - $153.99 $315,971 - $437,793
-2,843 Reduced 27.96%
7,325 $961 Million
Q4 2019

Jun 17, 2024

SELL
$127.5 - $146.44 $377,272 - $433,315
-2,959 Reduced 29.1%
7,209 $1.05 Billion
Q3 2019

Jun 17, 2024

SELL
$126.95 - $142.14 $385,674 - $431,821
-3,038 Reduced 29.88%
7,130 $923 Million
Q2 2019

Jun 17, 2024

SELL
$131.15 - $144.24 $423,352 - $465,606
-3,228 Reduced 31.75%
6,940 $967 Million
Q1 2019

Jun 17, 2024

SELL
$125.72 - $139.79 $405,572 - $450,962
-3,226 Reduced 31.73%
6,942 $970 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $414B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Traphagen Investment Advisors LLC Portfolio

Follow Traphagen Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traphagen Investment Advisors LLC with notifications on news.